Business Wire

JPMorganChase Announces Intention to Build a New Three-Million Sq Ft Landmark Tower in London

27.11.2025 07:00:00 CET | Business Wire | Press Release

Share

JPMorganChase is proud to announce its intention to build a new three-million square feet tower in London. This transformative project would enable additional capacity for the firm to grow by creating a world-class workplace for up to 12,000employees, further strengthening London’s position as a global financial hub. The plans are subject to a continuing positive business environment in the UK and the receipt of the necessary approvals and agreements at a national and local level.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251126040802/en/

Artist's impression: The view from JPMorganChase's Riverside office

Serving as the firm’s principal headquarters in the UK and its most significant presence in EMEA, the building would be situated on the Riverside development in Canary Wharf. The plans will provide employees and clients with a first-class working environment against a backdrop of uninterrupted views across the River Thames to central London.

The building is being designed by British architects, Foster + Partners, who also designed the firm’s iconic global headquarters at 270 Park Avenue in New York City. Its construction is expected to take six years and will begin as soon as necessary approvals and agreements are in place. Canary Wharf Group is working as co-developer on the project, and the firm is being advised independently by Sir George Iacobescu.

Jamie Dimon, Chairman & CEO of JPMorganChase, said: “London has been a trading and financial hub for more than a thousand years, and maintaining it as a vibrant place for finance and business is critical to the health of the UK economy. This building will represent our lasting commitment to the city, the UK, our clients and our people. The UK government’s priority of economic growth has been a critical factor in helping us make this decision.”

While the building is constructed, JPMorganChase will also make interim upgrades to the interior of its existing building at 25 Bank Street. An independent study commissioned by the bank with a major consulting firm estimates that the combined project could contribute approximately £9.9 billion ($13 billion) to the UK economy over the next six years, creating more than 7,800 jobs across construction and other local industries. It also found that, through JPMorganChase’s 13,000 employees and operations in London, the firm contributes nearly £7.5 billion ($9.8 billion) annually to the local economy, supporting 38,000 jobs across the surrounding ecosystem.

Rachel Reeves, UK Chancellor of the Exchequer, said: “My Budget doubles down on growth as our number one priority by creating the conditions for businesses to invest and succeed. I am thrilled that JPMorganChase has chosen London for its landmark new building - a multi-billion pound vote of confidence in the UK economy and this government’s plans for growth, which are built on the rock of stability.”

Sir Sadiq Khan, Mayor of London, said:“JPMorganChase’s landmark investment in a new building here in London is a huge vote of confidence in the capital’s future and a testament to our enduring status as a global powerhouse for finance, innovation, and talent. London is open to investment and the huge opportunities that it brings. This major commitment will create jobs and further strengthen London’s position at the centre of the global economy, driving growth across the UK.”

Lutfur Rahman, Executive Mayor of the London Borough of Tower Hamlets, said: “As Executive Mayor of Tower Hamlets, I am proud of the success of Canary Wharf, which is creating investment and job opportunities for local residents and boosting the ecosystem around local businesses. This announcement from JPMorganChase is fantastic and welcome news for the long-term prosperity of our Borough. We are excited by the opportunity that this investment can bring including the creation of a new world class park on the River Thames and the shared space for our community, Londoners and visitors to our city to enjoy.”

Modern community space and an investment in employees

In collaboration with Canary Wharf Group, plans include new public parkland surrounding the building, a redevelopment of the Canary Wharf dock, and improved access to the Riverside area of Canary Wharf. The building itself will provide exceptional collaboration spaces, and state of the art trading floors. It will support employees’ physical and emotional well-being with facilities including: terraces and roof-tops, wellness spaces, nursing rooms, restaurants and cafés, and ample bicycle parking spaces.

Conor Hillery, Co-CEO of JPMorganChase in EMEA, said: “There should be no doubt about the enduring appeal of London as a world-class financial centre, and this investment would prove it. This is something for our employees to look forward to, and we can’t wait to get the construction underway.”

Matthieu Wiltz, Co-CEO of JPMorganChase in EMEA, added: “So many of us across Europe have built our finance careers in London, and we are aiming to build a legacy that will benefit the city and its communities for generations to come.”

Shobi Khan, CEO of Canary Wharf Group, said: “We are delighted that JPMorganChase has once again chosen Canary Wharf as their primary UK location. The scale and ambition of this scheme - set to become the largest office building in London - demonstrates the continued momentum behind Canary Wharf’s evolution and JPMorganChase's commitment to outstanding workplaces.”

JPMorganChase currently operates in London primarily from two main buildings that it owns: 25 Bank Street in Canary Wharf (for its Commercial & Investment Bank) and 60 Victoria Embankment in the City (for Asset & Wealth Management). It also leases space at One Cabot Square to accommodate its International Consumer Bank, including Chase UK, which continues to grow and now has over 2.6 million customers. Once the Riverside development is complete, London-based employees will consolidate in the new building as well as the existing property at 60 Victoria Embankment, and the firm will consider its options for 25 Bank Street.

This news follows another recent investment announcement from the firm of up to £350 million (over $450 million) in its Bournemouth campus. More information can be found here.

Expansion of Security & Resiliency Initiative

Extending on this commitment, JPMorganChase will in the coming months bring its Security & Resiliency Initiative (SRI) to the UK. First announced in the US in October, SRI is a $1.5 trillion, 10-year plan to facilitate, finance and invest in key strategic areas such as: defence and aerospace, energy independence and the supply chains for critical minerals and advanced manufacturing. As in the US, the UK commitment will include direct equity and venture capital investments from JPMorganChase, and further details will follow soon.

Working to boost skills and jobs training in the UK

JPMorganChase is committed to working with local communities wherever it is based. In 2024, the firm expanded its commitment to the UK by announcing £40 million in new investments over five years to help connect young people and underserved communities to economic opportunities – bringing the firm’s total commitment since 2019 to £90 million.

Since then, the firm has deployed over £10 million in the programme’s first year through support for non-profit organisations such as the Careers & Enterprise Company, Young Enterprise, Nest Insights, and other partners. Beyond this deployment, which focuses on financial health and skills, JPMorganChase has also provided an additional £5.2 million to support small businesses in the UK. More information can be found here.

The bank has also worked closely for many years with organisations in the borough of Tower Hamlets, where Canary Wharf is situated. Over the past two years, 370 JPMorganChase employees have helped over 1,600 Tower Hamlets secondary school students build employability skills through the firm’s work with non-profit, The Switch.

JPMorganChase is committed to working collaboratively with the community and the UK government to deliver the Riverside project that reflects a shared vision for the future of London.

About JPMorganChase in the UK

With a legacy dating back more than 200 years in the UK, JPMorganChase has a track record of demonstrating leadership during times of both economic growth and financial instability. The firm provides £600 billion in credit and capital to nearly 4,500 medium and large companies and supports over two and a half million retail customers. In the UK’s Innovation Economy sector, made up of early stage high growth venture capital backed companies, JPMorganChase is aiming to lend more than $2 billion by 2030.

At the same time, together with its non-profit partners the firm has supported over 33,300 low income households reduce their debt and improve their financial health, helped nearly 20,000 small businesses to grow their activity and placed over 9,800 individuals into apprenticeships or full and part-time employment.

JPMorganChase has 23,000 employees in the UK, including: 13,000 in London, 5,300 in Bournemouth and 4,000 in Glasgow and Edinburgh.

About JPMorganChase

JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorganChase had $4.6 trillion in assets and $360 billion in stockholders’ equity as of September 30, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251126040802/en/

Contacts

Media Contact:
Patrick Burton
+44 20 7134 9041
patrick.o.burton@jpmorgan.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye